Multiple Myeloma Treatment Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Myeloma Treatment Market Size Growth Rate by Type: 2017 VS 2022 VS 2030
1.2.2 Proteasome Inhibitors
1.2.3 Immunomodulatory Agents (IMiDs)
1.2.4 Histone Deacetylase (HDAC) Inhibitors
1.2.5 Immunotherapy
1.2.6 Cytotoxic Chemotherapy
1.3 Market by Application
1.3.1 Global Multiple Myeloma Treatment Market Share by Application: 2017 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Treatment and Rehabilitation Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Multiple Myeloma Treatment Market Perspective (2017-2030)
2.2 Multiple Myeloma Treatment Growth Trends by Region
2.2.1 Multiple Myeloma Treatment Market Size by Region: 2017 VS 2022 VS 2030
2.2.2 Multiple Myeloma Treatment Historic Market Size by Region (2017-2023)
2.2.3 Multiple Myeloma Treatment Forecasted Market Size by Region (2023-2030)
2.3 Multiple Myeloma Treatment Market Dynamics
2.3.1 Multiple Myeloma Treatment Industry Trends
2.3.2 Multiple Myeloma Treatment Market Drivers
2.3.3 Multiple Myeloma Treatment Market Challenges
2.3.4 Multiple Myeloma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiple Myeloma Treatment Players by Revenue
3.1.1 Global Top Multiple Myeloma Treatment Players by Revenue (2017-2023)
3.1.2 Global Multiple Myeloma Treatment Revenue Market Share by Players (2017-2023)
3.2 Global Multiple Myeloma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiple Myeloma Treatment Revenue
3.4 Global Multiple Myeloma Treatment Market Concentration Ratio
3.4.1 Global Multiple Myeloma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Treatment Revenue in 2022
3.5 Multiple Myeloma Treatment Key Players Head office and Area Served
3.6 Key Players Multiple Myeloma Treatment Product Solution and Service
3.7 Date of Enter into Multiple Myeloma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiple Myeloma Treatment Breakdown Data by Type
4.1 Global Multiple Myeloma Treatment Historic Market Size by Type (2017-2023)
4.2 Global Multiple Myeloma Treatment Forecasted Market Size by Type (2023-2030)
5 Multiple Myeloma Treatment Breakdown Data by Application
5.1 Global Multiple Myeloma Treatment Historic Market Size by Application (2017-2023)
5.2 Global Multiple Myeloma Treatment Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Multiple Myeloma Treatment Market Size (2017-2030)
6.2 North America Multiple Myeloma Treatment Market Size by Country (2017-2023)
6.3 North America Multiple Myeloma Treatment Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Multiple Myeloma Treatment Market Size (2017-2030)
7.2 Europe Multiple Myeloma Treatment Market Size by Country (2017-2023)
7.3 Europe Multiple Myeloma Treatment Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiple Myeloma Treatment Market Size (2017-2030)
8.2 Asia-Pacific Multiple Myeloma Treatment Market Size by Country (2017-2023)
8.3 Asia-Pacific Multiple Myeloma Treatment Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Multiple Myeloma Treatment Market Size (2017-2030)
9.2 Latin America Multiple Myeloma Treatment Market Size by Country (2017-2023)
9.3 Latin America Multiple Myeloma Treatment Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiple Myeloma Treatment Market Size (2017-2030)
10.2 Middle East & Africa Multiple Myeloma Treatment Market Size by Country (2017-2023)
10.3 Middle East & Africa Multiple Myeloma Treatment Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Multiple Myeloma Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Multiple Myeloma Treatment Business (2017-2023)
11.1.5 Johnson & Johnson Recent Development
11.2 Roche Holding
11.2.1 Roche Holding Company Detail
11.2.2 Roche Holding Business Overview
11.2.3 Roche Holding Multiple Myeloma Treatment Introduction
11.2.4 Roche Holding Revenue in Multiple Myeloma Treatment Business (2017-2023)
11.2.5 Roche Holding Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Multiple Myeloma Treatment Introduction
11.3.4 Sanofi Revenue in Multiple Myeloma Treatment Business (2017-2023)
11.3.5 Sanofi Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Multiple Myeloma Treatment Introduction
11.4.4 Eli Lilly Revenue in Multiple Myeloma Treatment Business (2017-2023)
11.4.5 Eli Lilly Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Multiple Myeloma Treatment Introduction
11.5.4 Novartis Revenue in Multiple Myeloma Treatment Business (2017-2023)
11.5.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Multiple Myeloma Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2022 VS 2030
Table 2. Key Players of Proteasome Inhibitors
Table 3. Key Players of Immunomodulatory Agents (IMiDs)
Table 4. Key Players of Histone Deacetylase (HDAC) Inhibitors
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Cytotoxic Chemotherapy
Table 7. Global Multiple Myeloma Treatment Market Size Growth by Application (US$ Million): 2017 VS 2022 VS 2030
Table 8. Global Multiple Myeloma Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2030
Table 9. Global Multiple Myeloma Treatment Market Size by Region (2017-2023) & (US$ Million)
Table 10. Global Multiple Myeloma Treatment Market Share by Region (2017-2023)
Table 11. Global Multiple Myeloma Treatment Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 12. Global Multiple Myeloma Treatment Market Share by Region (2023-2030)
Table 13. Multiple Myeloma Treatment Market Trends
Table 14. Multiple Myeloma Treatment Market Drivers
Table 15. Multiple Myeloma Treatment Market Challenges
Table 16. Multiple Myeloma Treatment Market Restraints
Table 17. Global Multiple Myeloma Treatment Revenue by Players (2017-2023) & (US$ Million)
Table 18. Global Multiple Myeloma Treatment Market Share by Players (2017-2023)
Table 19. Global Top Multiple Myeloma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Treatment as of 2022)
Table 20. Ranking of Global Top Multiple Myeloma Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Multiple Myeloma Treatment Revenue (CR5 and HHI) & (2017-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Multiple Myeloma Treatment Product Solution and Service
Table 24. Date of Enter into Multiple Myeloma Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiple Myeloma Treatment Market Size by Type (2017-2023) & (US$ Million)
Table 27. Global Multiple Myeloma Treatment Revenue Market Share by Type (2017-2023)
Table 28. Global Multiple Myeloma Treatment Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 29. Global Multiple Myeloma Treatment Revenue Market Share by Type (2023-2030)
Table 30. Global Multiple Myeloma Treatment Market Size by Application (2017-2023) & (US$ Million)
Table 31. Global Multiple Myeloma Treatment Revenue Market Share by Application (2017-2023)
Table 32. Global Multiple Myeloma Treatment Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 33. Global Multiple Myeloma Treatment Revenue Market Share by Application (2023-2030)
Table 34. North America Multiple Myeloma Treatment Market Size by Country (2017-2023) & (US$ Million)
Table 35. North America Multiple Myeloma Treatment Market Size by Country (2023-2030) & (US$ Million)
Table 36. Europe Multiple Myeloma Treatment Market Size by Country (2017-2023) & (US$ Million)
Table 37. Europe Multiple Myeloma Treatment Market Size by Country (2023-2030) & (US$ Million)
Table 38. Asia-Pacific Multiple Myeloma Treatment Market Size by Region (2017-2023) & (US$ Million)
Table 39. Asia-Pacific Multiple Myeloma Treatment Market Size by Region (2023-2030) & (US$ Million)
Table 40. Latin America Multiple Myeloma Treatment Market Size by Country (2017-2023) & (US$ Million)
Table 41. Latin America Multiple Myeloma Treatment Market Size by Country (2023-2030) & (US$ Million)
Table 42. Middle East & Africa Multiple Myeloma Treatment Market Size by Country (2017-2023) & (US$ Million)
Table 43. Middle East & Africa Multiple Myeloma Treatment Market Size by Country (2023-2030) & (US$ Million)
Table 44. Johnson & Johnson Company Detail
Table 45. Johnson & Johnson Business Overview
Table 46. Johnson & Johnson Multiple Myeloma Treatment Product
Table 47. Johnson & Johnson Revenue in Multiple Myeloma Treatment Business (2017-2023) & (US$ Million)
Table 48. Johnson & Johnson Recent Development
Table 49. Roche Holding Company Detail
Table 50. Roche Holding Business Overview
Table 51. Roche Holding Multiple Myeloma Treatment Product
Table 52. Roche Holding Revenue in Multiple Myeloma Treatment Business (2017-2023) & (US$ Million)
Table 53. Roche Holding Recent Development
Table 54. Sanofi Company Detail
Table 55. Sanofi Business Overview
Table 56. Sanofi Multiple Myeloma Treatment Product
Table 57. Sanofi Revenue in Multiple Myeloma Treatment Business (2017-2023) & (US$ Million)
Table 58. Sanofi Recent Development
Table 59. Eli Lilly Company Detail
Table 60. Eli Lilly Business Overview
Table 61. Eli Lilly Multiple Myeloma Treatment Product
Table 62. Eli Lilly Revenue in Multiple Myeloma Treatment Business (2017-2023) & (US$ Million)
Table 63. Eli Lilly Recent Development
Table 64. Novartis Company Detail
Table 65. Novartis Business Overview
Table 66. Novartis Multiple Myeloma Treatment Product
Table 67. Novartis Revenue in Multiple Myeloma Treatment Business (2017-2023) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Research Programs/Design for This Report
Table 70. Key Data Information from Secondary Sources
Table 71. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Myeloma Treatment Market Share by Type: 2022 VS 2030
Figure 2. Proteasome Inhibitors Features
Figure 3. Immunomodulatory Agents (IMiDs) Features
Figure 4. Histone Deacetylase (HDAC) Inhibitors Features
Figure 5. Immunotherapy Features
Figure 6. Cytotoxic Chemotherapy Features
Figure 7. Global Multiple Myeloma Treatment Market Share by Application in 2022 & 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Cancer Treatment and Rehabilitation Centers Case Studies
Figure 11. Multiple Myeloma Treatment Report Years Considered
Figure 12. Global Multiple Myeloma Treatment Market Size (US$ Million), Year-over-Year: 2017-2030
Figure 13. Global Multiple Myeloma Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2030
Figure 14. Global Multiple Myeloma Treatment Market Share by Region: 2022 VS 2030
Figure 15. Global Multiple Myeloma Treatment Market Share by Players in 2022
Figure 16. Global Top Multiple Myeloma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Multiple Myeloma Treatment Revenue in 2022
Figure 18. North America Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 19. North America Multiple Myeloma Treatment Market Share by Country (2017-2030)
Figure 20. United States Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 21. Canada Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 22. Europe Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 23. Europe Multiple Myeloma Treatment Market Share by Country (2017-2030)
Figure 24. Germany Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 25. France Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 26. U.K. Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 27. Italy Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 28. Russia Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 29. Nordic Countries Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 30. Asia-Pacific Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 31. Asia-Pacific Multiple Myeloma Treatment Market Share by Region (2017-2030)
Figure 32. China Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 33. Japan Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 34. South Korea Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 35. Southeast Asia Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 36. India Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 37. Australia Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 38. Latin America Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 39. Latin America Multiple Myeloma Treatment Market Share by Country (2017-2030)
Figure 40. Mexico Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 41. Brazil Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 42. Middle East & Africa Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 43. Middle East & Africa Multiple Myeloma Treatment Market Share by Country (2017-2030)
Figure 44. Turkey Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 45. Saudi Arabia Multiple Myeloma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 46. Johnson & Johnson Revenue Growth Rate in Multiple Myeloma Treatment Business (2017-2023)
Figure 47. Roche Holding Revenue Growth Rate in Multiple Myeloma Treatment Business (2017-2023)
Figure 48. Sanofi Revenue Growth Rate in Multiple Myeloma Treatment Business (2017-2023)
Figure 49. Eli Lilly Revenue Growth Rate in Multiple Myeloma Treatment Business (2017-2023)
Figure 50. Novartis Revenue Growth Rate in Multiple Myeloma Treatment Business (2017-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Industry Market Size
